NPCE R&D to Revenue
Neuropace Inc · R&D to Revenue
NPCE R&D to Revenue
Latest reported30.22%period ending
NPCE Quarterly R&D/Revenue (48.45% → 30.22%)
Latest values, visible window
High-resolution chart · PNG
NPCE r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 30.2199% | |
| 32.5766% | |
| 26.4292% | |
| 24.0404% | |
| 29.1029% | |
| 33.0314% | |
| 28.1841% | |
| 27.3219% | |
| 31.4967% | |
| 31.9135% | |
| 29.8523% | |
| 29.1897% | |
| 32.3622% | |
| 36.3668% | |
| 39.792% | |
| 50.2913% | |
| 55.5784% | |
| 49.0329% | |
| 48.6042% | |
| 41.8706% | |
| 35.1306% | |
| 36.5517% | |
| 36.449% | |
| 28.9014% | |
| 42.5654% | |
| 48.4511% |